<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01006954</url>
  </required_header>
  <id_info>
    <org_study_id>Royan-Emb-003</org_study_id>
    <nct_id>NCT01006954</nct_id>
  </id_info>
  <brief_title>Outcome of Two Protocols in Poor Responders in Assisted Reproductive Technology (ART) Cycle</brief_title>
  <official_title>Comparison of Micro Dose Gonadotropin-Releasing Hormone (GnRH) Agonist Flare up &amp; Flare Protocol in Poor Responders in Assisted Reproductive Technology (ART) Cycle</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Royan Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Royan Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      About 9 to 24 % of women undergoing in vitro fertilization (IVF) treatment respond poorly to
      the usual gonadotrophin stimulation protocol applied. Several induction ovulation treatments
      have been suggested for increasing pregnancy rate. In this study, the investigators will
      compare the outcome of Microflare protocol and Flare up regimen in poor responders.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized clinical trial study, a total of 200 infertile women with poor ovarian
      response who undergo IVF / ICSI treatment cycle at Royan Institute will enroll in this study
      and will randomly be divided into two groups of 100 patients. This study has been approved by
      Royan ethics committee and written consent will be obtained from each patient.

      The patients will be randomized to one of two groups of Flare Up or Microdose GnRh agonist
      flare up.

      Luteinizing Hormone (LH), Follicle Stimulating Hormone (FSH), Estradiol, will be evaluated on
      day 2 or 3 and when follicle size become &gt;14.

      2 weeks after embryo transfer, the patients will be tested for serum β-hCG for assessing the
      pregnancy. The clinical pregnancy will be clarified by the number of women with gestational
      sacs on transvaginal sonography at 4-6 weeks of gestation. In the calculation of
      implantation, the number of gestational sacs will be considered.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">February 2010</completion_date>
  <primary_completion_date type="Actual">January 2010</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pregnancy rate</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cycle cancellation rates</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of oocytes generated</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of embryos generated</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Implantation rate</measure>
    <time_frame>12 Months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Flare Up</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Flare up protocol in poor responders for IVF/ICSI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microdose GnRh</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Microflare protocol in poor responders for IVF/ICSI</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Microdose GnRh</intervention_name>
    <description>Microflare protocol in poor responders for IVF/ICSI</description>
    <arm_group_label>Microdose GnRh</arm_group_label>
    <other_name>Case</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Flare up</intervention_name>
    <description>Flare up protocol in poor responders for IVF/ICSI</description>
    <arm_group_label>Flare Up</arm_group_label>
    <other_name>Standard treatment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Poor responders (Presence of at least two of following items is necessary for inclusion to
        the study)

          -  History of Cycle Cancellation

          -  History of oocyte number 3 (in previous cycle)

          -  History of Number of antral follicle &lt; 5 in previous cycle

          -  Age≥38

          -  FSH&gt;12 on day 2 or 3

          -  Ovarian Volume 3 cm3

        Exclusion Criteria:

          -  Male factor (azospermi)

          -  Myoma ≥6cm

          -  One way ovary

          -  Tumor or cyst &gt;13mm

          -  Age &gt;42
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tahereh Madani, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Royan Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Firoozeh Ghaffari, MD</last_name>
    <role>Study Director</role>
    <affiliation>Royan Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tahereh Madani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Royan Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>1- Endocrinology and Female Infertility Department, Reproductive Medicine Research Centre, Royan Institute, ACECR</name>
      <address>
        <city>Tehran</city>
        <zip>14114</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <link>
    <url>http://WWW.Royaninstitute.org</url>
  </link>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 2, 2009</study_first_submitted>
  <study_first_submitted_qc>November 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2009</study_first_posted>
  <last_update_submitted>May 7, 2014</last_update_submitted>
  <last_update_submitted_qc>May 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 8, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Poor responder</keyword>
  <keyword>Flare up</keyword>
  <keyword>Micro dose GnRH agonist flare up</keyword>
  <keyword>IVF/ICSI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

